ClinicalTrials.Veeva

Menu

Post-Market Registry in Europe and US for the Use of VascuCelTM

L

LeMaitre Vascular

Status

Active, not recruiting

Conditions

Suture Line Buttressing
Peripheral Vessel Reconstruction
Great Vessel Reconstruction

Treatments

Device: great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing

Study type

Observational

Funder types

Industry

Identifiers

NCT04906824
GLRA-G011

Details and patient eligibility

About

This is a post-market, multi-centre, open-label registry designed to collect prospective safety and performance data on the use of VascuCel in patients who require great vessel reconstruction, peripheral vascular reconstruction or suture line buttressing. This registry will collect safety and performance data up to 2 years following implantation.

Full description

Post-market, prospective, multi-centre, open-label, registry designed to collect prospective safety and performance data on the use of VascuCel in patients with vascular disorders and in accordance with local standard of care. The Registry has been designed to collect data up to 2 years following implantation. The VascuCel Registry will collect data on the use of the VascuCel, for the following major indications:

  • Great vessel reconstruction
  • Peripheral vascular reconstruction

As suture line buttressing is a procedure that does not consistently use tissue, data on this indication will only be included if available. Data will be prospectively collected by the sites on registry-specific electronic case report forms (eCRFs). The primary endpoints will assess device's safety and performance through measures and images obtained via the facility's standard of care at the respective registry site. Additional data will also be collected from the implant procedure to assess user (surgeon) satisfaction with the devices' handling and performance.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient has signed the informed consent
  • patient is a candidate for treatment with VascuCel per approved device indications.

Exclusion criteria

  • no study specific exclusion criteria; patients treated per standard clinical practice

Trial contacts and locations

5

Loading...

Central trial contact

Ioana Ghiu; Marit Balder

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems